Hereditary angioedema (HAE) multi-national survey study

Not Applicable

• Conditions: Hereditary angioedema quality of life for patients and caregivers; Circulatory System

• Registration Number: ISRCTN85479564
• Lead Sponsor: Takeda (Switzerland)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-10-31
• Last Update Posted: 14 November 2022
• Study Completion: 2023-02-28

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 750

Inclusion Criteria

1. Self-reported diagnosis of HAE (Types I, II, normal functioning C1-INH, or unknown type)
2. Age 18 years or older
3. Experienced at least 1 episode of angioedema or prodromal symptoms within the last year
4. Has been treated with a prescription medication for an angioedema attack within the last 2 years
5. Able to understand and provide consent
6. Willing to complete an web-based survey
7. Adequate fluency in the target language in which the survey is designed:
7.1. Spanish (Argentina & Colombia)
7.2. Brazilian Portuguese (Brazil)
7.3. Croatian (Croatia)
7.4. Danish (Denmark)
7.5. Hungarian (Hungary)
7.6. English (Ireland)
7.7. Norwegian (Norway)
7.8. Polish (Poland)
7.9. Portuguese (Portugal)
7.10. Romanian (Romania)
7.11. Swedish (Sweden)

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

• Study Type: Observational
• Study Design: Not specified